MX2011009709A - Compuestos para el tratamiento de la inflamacion y del dolor. - Google Patents

Compuestos para el tratamiento de la inflamacion y del dolor.

Info

Publication number
MX2011009709A
MX2011009709A MX2011009709A MX2011009709A MX2011009709A MX 2011009709 A MX2011009709 A MX 2011009709A MX 2011009709 A MX2011009709 A MX 2011009709A MX 2011009709 A MX2011009709 A MX 2011009709A MX 2011009709 A MX2011009709 A MX 2011009709A
Authority
MX
Mexico
Prior art keywords
pain
methylsulfonyl
treating inflammation
butyric acid
present
Prior art date
Application number
MX2011009709A
Other languages
English (en)
Spanish (es)
Inventor
Joseph P St Laurent
Original Assignee
Olatec Ind Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olatec Ind Llc filed Critical Olatec Ind Llc
Publication of MX2011009709A publication Critical patent/MX2011009709A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/02Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX2011009709A 2009-03-18 2010-03-16 Compuestos para el tratamiento de la inflamacion y del dolor. MX2011009709A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16128509P 2009-03-18 2009-03-18
PCT/US2010/027501 WO2010107807A2 (en) 2009-03-18 2010-03-16 Compounds for treating inflammation and pain

Publications (1)

Publication Number Publication Date
MX2011009709A true MX2011009709A (es) 2011-12-06

Family

ID=42738194

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011009709A MX2011009709A (es) 2009-03-18 2010-03-16 Compuestos para el tratamiento de la inflamacion y del dolor.

Country Status (11)

Country Link
US (1) US7851650B2 (enExample)
EP (1) EP2408740B1 (enExample)
JP (1) JP5587969B2 (enExample)
KR (1) KR20110128348A (enExample)
CN (1) CN102438983A (enExample)
AU (1) AU2010226794A1 (enExample)
BR (1) BRPI1014528A2 (enExample)
CA (1) CA2755678A1 (enExample)
MX (1) MX2011009709A (enExample)
RU (1) RU2520034C2 (enExample)
WO (1) WO2010107807A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2531026A4 (en) * 2010-02-04 2013-09-25 Novabay Pharmaceuticals Inc ANTIMICROBIAL FORMULATIONS ON POLYSACCHARID BASE
JP5932830B2 (ja) 2010-12-15 2016-06-08 オラテック セラピューティクス リミティド ライアビリティ カンパニー 炎症及び疼痛を処置するための3‐メタンスルホニルプロピオニトリル
US8802885B2 (en) 2012-02-27 2014-08-12 Olatec Industries Llc Process for preparing 3-methylsulfonylpropionitrile
US9481644B2 (en) 2012-06-05 2016-11-01 Olatec Therapeutics Llc Pharmaceutical composition comprising omega-(arylsulfonyl)alkylnitrile
CN104411303B (zh) * 2012-06-05 2017-09-05 欧拉泰克工业有限责任公司 用于治疗皮肤炎性疾病的方法
WO2013184708A1 (en) * 2012-06-05 2013-12-12 Olatec Industries Llc Pharmaceutical composition for treating inflammation and pain
AU2013271773B2 (en) * 2012-06-05 2018-03-08 Olatec Therapeutics Llc Pharmaceutical composition for treating inflammation and pain
MX368641B (es) 2012-06-11 2019-10-09 Olatec Ind Llc Compuestos para el tratamiento de inflamación y dolor.
WO2013188314A1 (en) * 2012-06-14 2013-12-19 Olatec Industries Llc Compounds for treating inflammation and pain
US9114122B2 (en) 2012-06-14 2015-08-25 Olatec Industries Llc Compounds for treating inflammation and pain
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
WO2015081188A1 (en) * 2013-11-27 2015-06-04 Olatec Industries Llc Pharmaceutical composition comprising omega-(arylsulfonyl)alkylnitrile
WO2025097064A1 (en) * 2023-11-03 2025-05-08 Mencanin Steve Novel ampoule for delivery of polymers for wound treatment

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3700729A1 (de) * 1987-01-13 1988-07-21 Boehringer Mannheim Gmbh Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
PT668933E (pt) * 1992-11-19 2003-02-28 Anticancer Inc Utilizacao de metioninase como agente anti-tumor em qimioterapia anti-metionina
US6706670B2 (en) 1996-08-30 2004-03-16 Solutia, Inc. Water soluble metal working fluids
US6638701B1 (en) * 2002-12-17 2003-10-28 Eastman Kodak Company Photographic element containing a red dye-forming pyrazolotriazole coupler
RU2232752C1 (ru) * 2003-04-04 2004-07-20 Общество с ограниченной ответственностью "Поливит" Способ получения фосфата или сукцината 2-амино-4-метилтио-(s-оксо-s-имино)-масляной кислоты
US7423064B2 (en) 2004-09-24 2008-09-09 Olatec Industries, Llc Composition for treating bacterial, viral, fungal diseases, inflammation and pain
TWI386201B (zh) * 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc N-鹵化胺基酸、n,n-二鹵化胺基酸與其衍生物;以及使用其之組合物與方法
WO2006118196A1 (ja) * 2005-04-27 2006-11-09 Ajinomoto Co., Inc. Dpp4阻害剤及びその医薬用途
AU2006340367B2 (en) * 2006-03-20 2012-12-20 Olatec Industries Llc Composition for treating bacterial, viral, fungal diseases, inflammation and pain
US20080287866A1 (en) * 2007-01-31 2008-11-20 Adam Heller Methods and compositions for the treatment of pain

Also Published As

Publication number Publication date
BRPI1014528A2 (pt) 2016-04-05
EP2408740A4 (en) 2012-08-08
EP2408740A2 (en) 2012-01-25
JP2012520888A (ja) 2012-09-10
EP2408740B1 (en) 2013-11-20
JP5587969B2 (ja) 2014-09-10
CN102438983A (zh) 2012-05-02
US20100240756A1 (en) 2010-09-23
WO2010107807A3 (en) 2011-01-13
RU2011142008A (ru) 2013-04-27
CA2755678A1 (en) 2010-09-23
KR20110128348A (ko) 2011-11-29
US7851650B2 (en) 2010-12-14
AU2010226794A1 (en) 2011-10-27
RU2520034C2 (ru) 2014-06-20
WO2010107807A2 (en) 2010-09-23

Similar Documents

Publication Publication Date Title
MX2011009709A (es) Compuestos para el tratamiento de la inflamacion y del dolor.
WO2012082718A3 (en) 3-methanesulfonylpropionitrile for treating inflammation and pain
MX2013012588A (es) Inhibidores de cinasa.
MX2013006846A (es) Inhibidores de la replicacion de los virus de la influenza.
EA201270570A1 (ru) Комбинированная терапия раковых заболеваний с помощью соединений-ингибиторов hsp90
MX338554B (es) Compuestos de fenil carbamato para usarse en aliviar o tratar el dolor.
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
MX2010002392A (es) Composiciones de brimonidina mejoradas para tratar eritema.
WO2015157559A3 (en) 10',11'-modified saxitoxins useful for the treatment of pain
MX2011011083A (es) Compuestos heterociclicos como inhibidores de mek.
WO2013028818A8 (en) Pyrimido- pyridazinone compounds and use thereof
PH12013500301A1 (en) Oxadiazole inhibitors of leukotriene production
EA201390626A1 (ru) Производные гидроксамовой кислоты и применение указанных производных в лечении бактериальных инфекций
WO2012050831A3 (en) Combination treatment for dermatological conditions
MX2021010046A (es) Nueva composicion terapeutica que contiene ingrediente activo de apomorfinas.
MX2013003638A (es) Tratamiento en combinacion para rosacea.
PH12012501552A1 (en) Therapeutic or prophylactic agent for biliary diseases
TN2014000031A1 (en) Use of organic compound for the treatment of noonan syndrome
MX2013002208A (es) Derivados de sulfonilpiperazina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes.
IN2013DN02555A (enExample)
WO2010022201A3 (en) Folinic acid derivatives for promoting bone growth
RU2015112121A (ru) Ми-рнк и их применение в способах и композициях для лечения и/или профилактики глазных состояний
WO2010002835A3 (en) Vinpocetine and eburnamonine derivatives for promoting bone growth
IN2014KN01113A (enExample)
PH12014501051A1 (en) Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions

Legal Events

Date Code Title Description
FG Grant or registration